Crystal structures of zidovudine- or lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215

被引：52
|
作者：
Chamberlain, PP
Ren, J
Nichols, CE
Douglas, L
Lennerstrand, J
Larder, BA
Stuart, DI
Stammers, DK
机构：
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England
[2] Oxford Ctr Mol Sci, Oxford OX1 3QT, England
[3] Visible Genet, Cambridge CB4 0GA, England
来源：
JOURNAL OF VIROLOGY | 2002年 / 76卷 / 19期
关键词：
D O I：
10.1128/JVI.76.19.10015-10019.2002
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Six structures of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) containing combinations of resistance mutations for zidovudine (AZT) (M41L and T215Y) or lamivudine (M184V) have been determined as inhibitor complexes. Minimal conformational changes in the polymerase or nonnucleoside RT inhibitor sites compared to the mutant RTMC (D67N, K70P, T215F, and K219N) are observed, indicating that such changes may occur only with certain combinations of mutations. Model building M41L and T215Y into HIV-1 RT-DNA and docking in ATP that is utilized in the pyrophosphorolysis reaction for AZT resistance indicates that some conformational rearrangement appears necessary in RT for ATP to interact simultaneously with the M41L and T215Y mutations.
引用
收藏
页码：10015 / 10019
页数：5
相关论文
共 50 条
  • [31] Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine
    Ntemgwa, Michel
    Wainberg, Mark A.
    Oliveira, Maureen
    Moisi, Daniela
    Lalonde, Richard
    Micheli, Valeria
    Brenner, Blurna G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) : 3861 - 3869
  • [32] Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: Genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS Clinical Trials Group protocol 315
    Kuritzkes, DR
    Sevin, A
    Young, B
    Bakhtiari, M
    Wu, HL
    St Clair, M
    Connick, E
    Landay, A
    Spritzler, J
    Kessler, H
    Lederman, MM
    JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02): : 491 - 497
  • [33] SEQUENCE-ANALYSIS OF REVERSE-TRANSCRIPTASE GENES OF ZIDOVUDINE (AZT)-RESISTANT AND (AZT)-SENSITIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS
    SHEEHY, N
    DESSELBERGER, U
    JOURNAL OF GENERAL VIROLOGY, 1993, 74 : 223 - 228
  • [34] Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance
    Hammond, JL
    Koontz, DL
    Bazmi, HZ
    Beadle, JR
    Hostetler, SE
    Kini, GD
    Aldern, KA
    Richman, DD
    Hostetler, KY
    Mellors, JW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1621 - 1628
  • [35] Novel drug resistance pattern associated with the mutations K70G and M184V in human immunodeficiency virus type 1 reverse transcriptase
    Bradshaw, D.
    Malik, S.
    Booth, C.
    Van Houtte, M.
    Pattery, T.
    Waters, A.
    Ainsworth, J.
    Geretti, A. M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) : 4489 - 4491
  • [36] Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro
    Miller, MD
    Anton, KE
    Mulato, AS
    Lamy, PD
    Cherrington, JM
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01): : 92 - 100
  • [37] Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity
    Logsdon, BC
    Vickrey, JF
    Martin, P
    Proteasa, G
    Koepke, JI
    Terlecky, SR
    Wawrzak, Z
    Winters, MA
    Merigan, TC
    Kovari, LC
    JOURNAL OF VIROLOGY, 2004, 78 (06) : 3123 - 3132
  • [38] The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations
    Miranda, LR
    Götte, M
    Liang, F
    Kuritzkes, DR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 2648 - 2656
  • [39] COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS WITH UNIQUE PATTERNS OF POL GENE-MUTATIONS
    SHAFER, RW
    KOZAL, MJ
    WINTERS, MA
    IVERSEN, AKN
    KATZENSTEIN, DA
    RAGNI, MV
    MEYER, WA
    GUPTA, P
    RASHEED, S
    COOMBS, R
    KATZMAN, M
    FISCUS, S
    MERIGAN, TC
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04): : 722 - 729
  • [40] A Role of Template Cleavage in Reduced Excision of Chain-Terminating Nucleotides by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing the M184V Mutation
    Acosta-Hoyos, Antonio J.
    Matsuura, Suzanne E.
    Meyer, Peter R.
    Scott, Walter A.
    JOURNAL OF VIROLOGY, 2012, 86 (09) : 5122 - 5133
12345